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Abstract: The issue of risk assessment in glaucoma has received increasing attention in the past few years since the 
publication of results from the Ocular Hypertension Treatment Study. Predictive models have been developed in order to 
estimate the risk that patients with ocular hypertension will develop glaucoma if left untreated. The purpose of this article 
is to review issues on the development and validation of predictive models to estimate risk of glaucoma development. 
Current models are reviewed and details about their development and validation are provided. 
WHY RISK CALCULATORS ARE NECESSARY? 
  Risk calculators or predictive models are an essential part 
of health care. They have been continuously developed in 
several areas of medicine and their use has significantly 
contributed to the management of many disorders. The 
identification of risk factors for development or progression 
of disease is a fundamental component in the construction of 
these models. The concept of risk factor became widespread 
in medicine ever since the landmark Framingham Heart 
Study first reported in the early 1960s that cigarette smoking, 
elevated blood cholesterol, and high blood pressure were 
predictors of the likelihood of dying from heart disease. 
Framingham investigators then started developing predictive 
models to evaluate the global risk of cardiovascular disease 
based on the summation of all major risk factors [1-3]. Risk 
assessment and prevention has contributed significantly to 
reduce mortality from cardiovascular disease and its 
successful implementation in this scenario has stimulated its 
application to several other areas. 
  Recently, the concept of risk assessment has also been 
applied to ophthalmology, more specifically, for assessment 
of the risk of development of glaucoma in patients with 
ocular hypertension. It is estimated that approximately 8% of 
adults over the age of 40 years in the United States have 
ocular hypertension [4]. While ocular hypertension is a 
common finding, clinicians do not know which patients to 
treat or which patients to monitor without treatment. In 2002, 
the publication of the results of the Ocular Hypertension 
Treatment Study (OHTS) stimulated a reassessment of the 
ways in which to evaluate and manage patients with ocular 
hypertension [5, 6]. Since the OHTS publication, several 
strategies for risk assessment in ocular hypertension have 
been proposed and some have been successfully 
implemented in clinical practice. Several predictive models 
(or risk calculators) have been proposed and their use in 
clinical practice is likely to provide a more objective and 
evidence-based approach to the management of patients with 
ocular hypertension. 
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  Although the information on individual risk factors may 
already help clinicians in management decisions, it is 
frequently difficult to integrate the information on the 
several risk factors and provide a global assessment for a 
particular patient. In that situation, predictive models or risk 
calculators may benefit clinicians in providing a more 
objective assessment of risk. Mansberger et al. [7] performed 
a survey of ophthalmologists to estimate their ability to 
predict the risk of glaucoma development in ocular 
hypertensive patients [7]. Ophthalmologists had the benefit 
of an oral review and written handouts summarizing the 
OHTS results. They found that ophthalmologists tended to 
underestimate the risk when compared to the actual risk 
found by a risk calculator. Ophthalmologists also had a large 
range of predictions, sometimes differing from the actual 
risk by 40%, illustrating the need for a more standardized 
method for risk assessment. In another study, Boland and 
colleagues demonstrated that the use of a risk calculator 
changed recommendations performed by clinicians and 
increased the measure of confidence in their 
recommendations, while also decreasing inconsistency [8]. 
DEVELOPMENT OF A PREDICTIVE MODEL TO 
ESTIMATE THE RISK OF GLAUCOMA 
DEVELOPMENT 
  The development of predictive models requires a series 
of complex steps which initially involve the acquisition and 
analysis of data from one or multiple longitudinal studies 
that have carefully followed patients over time. A critical 
step is the identification of the risk factors associated with 
the outcome one wants to predict. A few large, prospective, 
longitudinal studies have provided evidence with regard to 
the risk factors for conversion from ocular hypertension to 
glaucoma. From these studies, two were randomized clinical 
trials, The Ocular Hypertension Treatment Study (OHTS) 
[5], and the European Glaucoma Prevention Study (EGPS) 
[9]. These two studies have provided the basis for 
development and validation of the prediction models for 
glaucoma development available today. Both studies have 
evaluated a large number of predictive factors for their 
potential association with the risk of converting to glaucoma. 
When pooled analyses of the OHTS and EGPS data were 
conducted, only 5 baseline factors were identified as   
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significantly associated with the risk of converting to 
glaucoma: age, intraocular pressure, central corneal 
thickness, the measurement of the vertical cup/disc ratio of 
the optic nerve and the visual field index pattern standard 
deviation (PSD) (Fig. 1) [10]. 
  Several other factors were not found to be statistically 
significantly related to the risk of conversion to glaucoma in 
the OHTS/EGPS pooled dataset, such as diabetes mellitus, 
history of heart disease and race, among others. It is 
important to emphasize, however, that even for the 
OHTS/EGPS combined dataset; the power of the study was 
probably not enough to detect a significant predictive value 
for many of the evaluated risk factors. Also, methodological 
weaknesses precluded a better investigation of the real value 
of potential risk factors, such as positive family history of 
glaucoma. As no relatives of the study subjects were 
examined, investigators had to rely on self-reported family 
history with its potential inaccuracy. It is likely that this 
contributed to the lack of association between family history 
and risk of glaucoma development as reported by these 
investigations. 
  After the information on risk factors is obtained, 
statistical methods can be applied to develop models for 
prediction of outcome using one or more explanatory 
variables. In 2005, we published the results on the 
development of a risk calculator to assess the risk of an 
ocular hypertensive patient to develop glaucoma [11]. The 
risk calculator was derived based on the results published by 
the OHTS [5, 12] and incorporated the variables that were  
 
described by that study as being significantly associated with 
the risk of developing glaucoma over time. The risk 
calculator was designed to estimate the chance of an ocular 
hypertensive patient to develop glaucoma if left untreated for 
5 years. To simplify the use of the risk calculator, a point 
system and an electronic version of the calculator were made 
available for clinicians. 
  A predictive model that is derived from a particular 
dataset is not guaranteed to work on a different group of 
patients. In fact, the performance of regression models (or 
risk calculators) used as diagnostic or prediction tools is 
generally better on the dataset on which the model has been 
constructed (derivation set) compared to the performance of 
the same model on new data. Therefore, before risk 
calculators can be successfully incorporated into clinical 
practice they need to be validated on different populations. 
By validation we mean establishing that the risk calculator 
works satisfactorily for patients other than those from whose 
data the model was derived. Along with the steps involved in 
the development of the risk calculator, we also presented the 
results of its validation on an independent population of 126 
patients with ocular hypertension who were followed as part 
of a prospective longitudinal study conducted at the 
University of California San Diego (DIGS – Diagnostic 
Innovations in Glaucoma Study). 
  Several steps were taken to validate the OHTS-derived 
model. In the first step, the importance of the prognostic 
variables that had been previously identified by the OHTS 
study was evaluated on the new data set (DIGS data set). All  
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the variables had similar performance, except for diabetes 
mellitus, which was not significantly associated with the risk 
of developing glaucoma in the DIGS data. Subsequently, the 
predictive performance of the model was investigated on the 
new data set. The ability of the OHTS-derived risk calculator 
to discriminate DIGS subjects who developed glaucoma 
from those who did not was reasonably good with a c-index 
of approximately 0.7. The c-index is a measure of the 
discriminating ability of a model (similar to the area under 
the Receiver Operating Characteristic [ROC] curve) and a c-
index of 0.7 indicates that, in approximately 70% of the 
cases, the model allocated a higher predicted probability for 
a subject who actually developed glaucoma than for a 
subject who did not. The closer the c-index gets to 1, the 
better the discriminating ability of the model. The values of 
c-index found for the OHTS-derived risk calculator when 
applied to DIGS subjects were similar to those found when 
risk models such as the Framingham coronary prediction 
scores are used to predict coronary heart disease events [2, 
13]. D’Agostino et al. reported c-indexes ranging from 0.63 
to 0.83 when the Framingham functions were applied to 6 
different cohorts of patients [2]. 
  The OHTS-derived risk calculator also had a good 
calibration when applied to the DIGS data set. Checking 
calibration is another important step in validating a 
predictive model. A reliable or well-calibrated model will 
give predicted probabilities that agree numerically with the 
actual outcomes. For example, let’s consider a group of 100 
ocular hypertensive patients. If the model assigns an average 
probability of 12% for conversion to glaucoma for this group 
of subjects, it is expected that approximately 12 subjects will 
convert to glaucoma over time. That is, for a well-calibrated 
model, the predicted probabilities of conversion to glaucoma 
will agree closely with the observed probabilities of 
conversion. The OHTS-derived risk calculator performed 
well on the DIGS data set. For patients in whom the model 
predicted a high chance of converting to glaucoma, there was 
a high observed conversion rate; whereas for patients in 
whom the model predicted a low conversion rate, there was a 
low observed conversion rate. 
  In 2007, OHTS and EGPS investigators published results 
of the development and validation of a risk calculator for 
glaucoma based on the analysis of the combined 
OHTS/EGPS dataset [10]. The results were similar to the 
predictive model published in 2005, and the risk calculator 
contained the 5 variables significantly associated with the 
risk of glaucoma conversion: age, IOP, CCT, PSD and 
vertical cup/disc ratio. The risk model from the pooled 
OHTS/EGPS sample of over 1,100 ocular hypertension 
patients demonstrated excellent fit with a c-statistic of 0.74 
and good calibration. The OHTS/EGPS risk calculator is 
available on the web at http://ohts.wustl.edu/risk. 
LIMITATIONS OF PREDICTIVE MODELS 
  The use of predictive models in clinical practice has 
several limitations. Predictive models are based on restricted  
 
 
 
 
populations of patients that were selected based on strict 
inclusion and exclusion criteria and that may not be 
representative of all patients seen at everyday clinical 
settings. Use of these models should be restricted to those 
patients who are similar to the ones included in the studies 
used to develop and/or validate it. It is also important to 
emphasize that although predictive models can provide a 
more objective evaluation of risk, their use does not replace 
the judgment of a clinician when making management 
decisions. For example, current risk calculators to estimate 
risk of glaucoma development do not include important 
information to guide treatment such as medical health status 
and life expectancy, patient’s willingness to treatment, costs 
of medications and overall effect of treatment on quality of 
life. Also, it is important to emphasize that current risk 
calculators for glaucoma have been designed to estimate the 
risk of development of the earliest signs of disease, which do 
not necessarily have an impact on the quality of vision of the 
patient. Finally, as more evidence regarding risk factors for 
disease development and progression accumulates, newer 
and better refined predictive models will be developed that 
should replace current existing ones. 
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